regarding ‘costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma bevacizumab in combination with interferon-α2a compared with sunitinib’
本文档由 mfe6e7 分享于2016-01-22 09:48
regarding ‘costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma bevacizumab in combination with interferon-α2a compared with sunitinib’
分享：
君，已阅读到文档的结尾了呢~~